首页> 美国卫生研究院文献>SAGE Open Medical Case Reports >Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure
【2h】

Late-onset cytomegalovirus pneumonitis successfully treated by cytomegalovirus immunoglobulin in heart transplant patient with renal failure

机译:通过肾功能衰竭的心脏移植患者患有巨细胞病毒免疫球蛋白成功治疗的晚期发病巨细胞病毒性肺炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytomegalovirus infection is one of the most serious pathogens affecting solid organ transplant recipients. Cytomegalovirus has been identified as a risk factor for graft rejection, cardiac allograft vasculopathy and is associated with increased morbidity and mortality. Viral clearance is not achieved in all patients despite standard antiviral therapy; therefore, there is great interest in prevention and treatment strategies, as use of specific cytomegalovirus immunoglobulin, to avoid progression to organ involvement. Dose regimen of specific cytomegalovirus immunoglobulin is not well studied, especially in cytomegalovirus disease. We present the case of late onset of tissue invasive disease, pneumonitis, in young female patient after heart transplantation with acute renal failure, successfully treated with frequent intermittent cytomegalovirus immunoglobulin followed by renal dosed ganciclovir.
机译:CytomeGalovirus感染是影响固体器官移植受体的最严重的病原体之一。已鉴定巨细胞病毒作为接枝排斥,心脏异种移植血管病变的危险因素,并且与发病率和死亡率增加有关。尽管标准抗病毒治疗,但所有患者都没有实现病毒清除;因此,对预防和治疗策略有很大的兴趣,因为使用特异性巨细胞病毒免疫球蛋白,以避免对器官受累的进展。特异性巨细胞病毒免疫球蛋白的剂量方案没有很好地研究,特别是在巨细胞病毒疾病中。我们展示了组织侵袭性疾病,肺炎患者在心脏移植急性肾功能衰竭后患儿侵袭性疾病,肺炎的案例,用频繁的间歇性细胞病毒免疫球蛋白,随后用肾剂量肾上腺素进行了成功治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号